{"url_path":"/sec/ixhl/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-057227-index.html","accession_number":"0001213900-26-057227","cik":"0001873875","ticker":"IXHL","issuer_name":"Incannex Healthcare Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-057227-index.html","primary_entity_key":"0001873875","primary_entity_name":"Incannex Healthcare Inc."},"word_count":428,"has_tables":true,"body_markdown":"UNITED\nSTATES\n\nSECURITIES\nAND EXCHANGE COMMISSION\n\nWashington,\nD.C. 20549\n\n \n\nFORM\n10-Q\n\n \n\n(Mark\nOne)\n\n☒\nQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor\nthe quarterly period ended March 31, 2026\n\n \n\nOR\n\n \n\n☐\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE\nACT OF 1934\n\n \n\nFOR\nTHE TRANSITION PERIOD FROM ___________ TO ___________\n\n \n\nCommission\nFile Number 001-41106\n\n \n\nIncannex\nHealthcare Inc.\n\n(Exact name of Registrant as specified in its charter)\n\n \n\nDelaware   93-2403210\n\n**(State or other jurisdiction of incorporation or organization)**   **(I.R.S. Employer Identification No.)**\n\n \n\nRialto South Tower\n\nLevel 23, 525 Collins Street\n\nMelbourne VIC 3008\n\nAustralia\n  Not applicable\n\n(Address of principal executive offices)   (Zip Code)\n\n \n\nRegistrant’s\ntelephone number, including area code: +61 409 840 786\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each class   Trading Symbol(s)   **Name of each exchange on which registered**\n\nCommon Stock, $0.0001 par value per share   IXHL   **The Nasdaq Capital Market**\n\n \n\nIndicate\nby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange\nAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)\nhas been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule\n405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant\nwas required to submit such files). Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,\nor an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller\nreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐\n\nNon-accelerated filer ☒ Smaller reporting company ☒\n\nEmerging growth company ☒    \n\n \n\nIf an emerging\ngrowth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any\nnew or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate\nby check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐\nNo ☒\n\n \n\nAs of May 15,\n2026, the registrant had 11,964,554 shares of common stock outstanding.\n\n \n\n \n\n \n\n \n\n \n\nTable\nof Contents\n\n \n\n \nPage\n\n[PART I—FINANCIAL INFORMATION](#a_001)\n1"}